New ulcerative colitis drug goes Head-to-Head with standard treatment
Disease control
Terminated
This study aimed to see if a new drug called AVT16 works as well as the existing drug Entyvio for controlling moderate to severe ulcerative colitis. It involved about 300 adults and directly compared the two treatments over a year. The study was designed to be fair, with neither …
Phase: PHASE3 • Sponsor: Alvotech Swiss AG • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC